Johnson & Johnson Analyst Ratings
HSBC Adjusts Price Target on Johnson & Johnson to $174 From $170, Maintains Buy Rating
HSBC Raises Price Target on Eli Lilly to $1,100 From $880, Maintains Buy Rating
Deutsche Bank Raises Price Target on UnitedHealth Group to $632 From $562, Keeps Buy Rating
Wells Fargo Adjusts Price Target on Apple to $275 From $225, Maintains Overweight Rating
Meta Platforms Analyst Ratings
Oppenheimer Adjusts Price Target on Meta Platforms to $525 From $500, Maintains Outperform Rating
UnitedHealth Group Analyst Ratings
UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Visa Analyst Ratings
Mastercard Analyst Ratings
Deutsche Bank Adjusts Price Target on Meta Platforms to $525 From $500
Microsoft Analyst Ratings
Johnson & Johnson (JNJ) Gets a Buy From RBC Capital
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating
TD Cowen Adjusts Price Target on Microsoft to $495 From $470, Maintains Buy Rating
JPMorgan Adjusts Price Target on Visa to $300 From $302, Maintains Overweight Rating
Goldman Sachs Adjusts Price Target on Apple to $265 From $238, Maintains Buy Rating